Brief: Avalon Globocare Expands Its Cellular Immuno-Oncology Platform With The Addition Of Novel Car-Nk Cell Therapies

Change Agents

14/02/2022 14:41

Feb 14 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE EXPANDS ITS CELLULAR IMMUNO-ONCOLOGY
PLATFORM
WITH THE ADDITION OF NOVEL CHIMERIC ANTIGEN RECEPTOR-NATURAL
KILLER (CAR-NK) CELL THERAPIES

Source text for Eikon:  ID:nGNX5XtvC3 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))